Table 3. Postoperative outcomes.
SRTAD (N = 17) | STAD (N = 34) | P | |
---|---|---|---|
ICU time (days) | 6.4 ± 3.1 | 7.6 ± 3.5 | 0.22 |
Ventilation >72 h | 5 (29.4%) | 8 (23.5%) | 0.65 |
DVT | 0 (0%) | 1 (2.9%) | 1 |
Transient neurologic dysfunction | 4 (23.5%) | 2 (5.9%) | 0.17 |
Pericardial effusion | 0 (0%) | 3 (8.8%) | 0.54 |
Pleural effusion | 4 (23.5%) | 11 (32.6%) | 0.75 |
ARF | 1 (5.9%) | 0 (0%) | 0.33 |
Paraparesis | 1 (5.9%) | 0 (0%) | 0.33 |
Infection | 0 (0%) | 2 (5.9%) | 0.55 |
Coma | 1 (5.9%) | 0 (0%) | 0.33 |
In-hospital death | 2 (11.8%) | 1 (2.9%) | <0.05 |
Data presented as mean ± standard deviation or n (%).
ARF: acute renal failure; DVT: deep vein thrombosis; ICU: intensive care unit; SRTAD: stent-related type A dissection; STAD: spontaneous type A dissection